Industry Dismisses Report’s Claim That Australians Pay Too Much For Medicines
Executive Summary
A study by the Australian think tank, the Grattan Institute, says that the government could save around A$500m simply by modifying some parts of the Pharmaceutical Benefits Scheme, but industry body Medicines Australia says the report’s findings are “inaccurate, selective and misleading.”